Applied DNA Sciences Inc APDN.OQ APDN.O is expected to show a rise in quarterly revenue when it reports results on December 5 (estimated) for the period ending September 30 2024
The Stony Brook New York-based company is expected to report a 15.3% increase in revenue to $899 thousand from $780 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Applied DNA Sciences Inc is for a loss of 34 cents per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated December 3 at 21:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments